Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
Emergency Medical Minute - Episode 954: Combo Rescue Inhalers - New Guidelines

Episode 954: Combo Rescue Inhalers - New Guidelines

04/30/25 • 3 min

1 Listener

Emergency Medical Minute

Contributor: Aaron Lessen, MD

Educational Pearls:

What is a Rescue Inhaler?

  • A rescue inhaler is a medication for people with asthma to quickly reverse the symptoms of an asthma attack.
  • Historically albuterol (Short Acting Beta Agonist (SABA)) monotherapy has been the mainstay rescue inhaler. This is because albuterol works fast and is relatively cheap. \n\n

What are Combination Rescue Inhalers?

  • Combination rescue inhalers contain a fast-acting bronchodilator as well as an inhaled corticosteroid (ICS)
  • The steroid helps to reduce some of the chronic airway inflammation that is worsening the asthma attack and can help to prevent future attacks
  • Examples include budesonide-formoterol and albuterol-budesonide
  • Global Initiative for Asthma (GINA), states that combination therapy is now the preferred reliever for adults and adolescents with mild asthma

What are the drawbacks of Combination Rescue Inhalers?

  • These inhalers are generally more expensive than just using a SABA inhaler which can be a barrier for some people \n\n
  • Improper use can also lead to conditions like thrush due to the addition of the steroid

References

  1. Krings JG, Beasley R. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today. J Allergy Clin Immunol Pract. 2024 Apr;12(4):870-879. doi: 10.1016/j.jaip.2024.01.011. Epub 2024 Jan 17. PMID: 38237858; PMCID: PMC10999356.
  2. Papi A, Chipps BE, Beasley R, Panettieri RA Jr, Israel E, Cooper M, Dunsire L, Jeynes-Ellis A, Johnsson E, Rees R, Cappelletti C, Albers FC. Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. N Engl J Med. 2022 Jun 2;386(22):2071-2083. doi: 10.1056/NEJMoa2203163. Epub 2022 May 15. PMID: 35569035.

Summarized by Jeffrey Olson, MS3 | Edited by Jorge Chalit, OMS3 \n\n

Donate: https://emergencymedicalminute.org/donate/

plus icon
bookmark

Contributor: Aaron Lessen, MD

Educational Pearls:

What is a Rescue Inhaler?

  • A rescue inhaler is a medication for people with asthma to quickly reverse the symptoms of an asthma attack.
  • Historically albuterol (Short Acting Beta Agonist (SABA)) monotherapy has been the mainstay rescue inhaler. This is because albuterol works fast and is relatively cheap. \n\n

What are Combination Rescue Inhalers?

  • Combination rescue inhalers contain a fast-acting bronchodilator as well as an inhaled corticosteroid (ICS)
  • The steroid helps to reduce some of the chronic airway inflammation that is worsening the asthma attack and can help to prevent future attacks
  • Examples include budesonide-formoterol and albuterol-budesonide
  • Global Initiative for Asthma (GINA), states that combination therapy is now the preferred reliever for adults and adolescents with mild asthma

What are the drawbacks of Combination Rescue Inhalers?

  • These inhalers are generally more expensive than just using a SABA inhaler which can be a barrier for some people \n\n
  • Improper use can also lead to conditions like thrush due to the addition of the steroid

References

  1. Krings JG, Beasley R. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today. J Allergy Clin Immunol Pract. 2024 Apr;12(4):870-879. doi: 10.1016/j.jaip.2024.01.011. Epub 2024 Jan 17. PMID: 38237858; PMCID: PMC10999356.
  2. Papi A, Chipps BE, Beasley R, Panettieri RA Jr, Israel E, Cooper M, Dunsire L, Jeynes-Ellis A, Johnsson E, Rees R, Cappelletti C, Albers FC. Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. N Engl J Med. 2022 Jun 2;386(22):2071-2083. doi: 10.1056/NEJMoa2203163. Epub 2022 May 15. PMID: 35569035.

Summarized by Jeffrey Olson, MS3 | Edited by Jorge Chalit, OMS3 \n\n

Donate: https://emergencymedicalminute.org/donate/

Previous Episode

undefined - Episode 953: Penicillin Allergies

Episode 953: Penicillin Allergies

1 Recommendations

Contributor: Geoff Hogan MD

Educational Pearls:

  • Penicillin allergies are relatively uncommon despite their frequent reports
    • 10% of the population reports a penicillin allergy but only 5% of these cases are clinically significant
    • 90-95% of patients may tolerate a rechallenge after appropriate allergy evaluation
  • Penicillin Allergy Decision Rule (PEN-FAST) on MD Calc
    • Useful tool to assess patients for penicillin allergies
    • Five years or less since reaction = 2 points (even if unknown)
    • Anaphylaxis or angioedema OR Severe cutaneous reaction = 2 points
    • Treatment required for reaction (e.g. epinephrine) = 1 point (even if unknown)
  • A score of 0 on PEN-FAST indicates a less than 1% risk of a positive penicillin allergy test
    • A score of 1 or 2 indicates a 5% risk of a positive penicillin allergy test
  • A low score on PEN-FAST should prompt clinicians to proceed with the best empiric antibiotic for the patient’s infection

References

  1. Broyles AD, Banerji A, Barmettler S, et al. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs [published correction appears in J Allergy Clin Immunol Pract. 2021 Jan;9(1):603. doi: 10.1016/j.jaip.2020.10.025.] [published correction appears in J Allergy Clin Immunol Pract. 2021 Jan;9(1):605. doi: 10.1016/j.jaip.2020.11.036.]. J Allergy Clin Immunol Pract. 2020;8(9S):S16-S116. doi:10.1016/j.jaip.2020.08.006
  2. Piotin A, Godet J, Trubiano JA, et al. Predictive factors of amoxicillin immediate hypersensitivity and validation of PEN-FAST clinical decision rule [published correction appears in Ann Allergy Asthma Immunol. 2022 Jun;128(6):740. doi: 10.1016/j.anai.2022.04.005.]. Ann Allergy Asthma Immunol. 2022;128(1):27-32. doi:10.1016/j.anai.2021.07.005
  3. Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and Management of Penicillin Allergy: A Review. JAMA. 2019;321(2):188-199. doi:10.1001/jama.2018.19283
  4. Trubiano JA, Vogrin S, Chua KYL, et al. Development and Validation of a Penicillin Allergy Clinical Decision Rule. JAMA Intern Med. 2020;180(5):745-752. doi:10.1001/jamainternmed.2020.0403

Summarized & edited by Jorge Chalit, OMS3

Donate: https://emergencymedicalminute.org/donate/

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/emergency-medical-minute-46703/episode-954-combo-rescue-inhalers-new-guidelines-90265467"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to episode 954: combo rescue inhalers - new guidelines on goodpods" style="width: 225px" /> </a>

Copy